NEW YORK (GenomeWeb News) — Illumina plans to buy back as much as $75 million of its outstanding common stock over a six-month period, and has filed a trading plan to allow it to complete the transactions.
Earlier this month Illumina said it would use $200 million from a senior note sale to buy back its own stock.